Nalaganje...
Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.
Herpes simplex virus type 1 (HSV-1) thymidine kinase is currently used as a suicide agent in the gene therapy of cancer. This therapy is based on the preferential phosphorylation of nucleoside analogs by tumor cells expressing HSV-1 thymidine kinase. However, the use of HSV-1 thymidine kinase is lim...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
1996
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC39643/ https://ncbi.nlm.nih.gov/pubmed/8622970 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|